Additive solutions differentially affect metabolic and functional parameters of platelet concentrates

Vox Sanguinis

Volumn 110, Issue 1, 2016, Pages 20-26

  Leitner, G C ^a   List, J ^b   Horvath, M ^a   Eichelberger, B ^a   Panzer, S ^a   Jilma Stohlawetz, P ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b HANUSCH HOSPITAL   (Austria)

Author keywords

Additive solution; Aggregation capacity; Platelets; Storage lesion

Indexed keywords

COLLAGEN; GLUCOSE; LACTATE DEHYDROGENASE; LACTIC ACID; PADGEM PROTEIN; PLATELET ADDITIVE SOLUTION; PRESERVATION SOLUTION; THROMBIN RECEPTOR ACTIVATING PEPTIDE; THROMBOCYTE CONCENTRATE; UNCLASSIFIED DRUG; PEPTIDE FRAGMENT; PRESERVATIVE; SELP PROTEIN, HUMAN; THROMBIN RECEPTOR PEPTIDE (42-47);

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD PH; BLOOD SAMPLING; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HEMATOLOGICAL PARAMETERS; HUMAN; LACTATE BLOOD LEVEL; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; METABOLIC PARAMETERS; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE PRESERVATION; THROMBOCYTE VOLUME; BLOOD CLOTTING PARAMETERS; BLOOD STORAGE; DRUG EFFECTS; METABOLISM; MIDDLE AGED; PROCEDURES; THROMBOCYTE;

ADULT; BLOOD PLATELETS; BLOOD PRESERVATION; HUMANS; MIDDLE AGED; P-SELECTIN; PEPTIDE FRAGMENTS; PLATELET ACTIVATION; PLATELET FUNCTION TESTS; PRESERVATIVES, PHARMACEUTICAL;

EID: 84956590593     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12317     Document Type: Article

References (27)

1. Alhumaidan H, Sweeney J: Current status of additive solutions for platelets. J Clin Apheresis 2012; 27:93-98
2. Andreu G, Vasse J, Herve F, et al.: Introduction of platelet additive solutions in transfusion practice. Advantages, disadvantages and benefit for patients. Transfus Clin Biol 2007; 14:100-106
3. Dumont LJ, Cancelas JA, Graminske S, et al.: In vitro and in vivo quality of leukoreduced apheresis platelets stored in a new platelet additive solution. Transfusion 2013; 53:972-980
4. Tobian AA, Savage WJ, Tisch DJ, et al.: Prevention of allergic transfusion reactions to platelets and red blood cells through plasma reduction. Transfusion 2011; 51:1676-1683
5. Cazenave JP, Isola H, Waller C, et al.: Use of additive solutions and pathogen inactivation treatment of platelet components in a regional blood center: impact on patient outcomes and component utilization during a 3-year period. Transfusion 2011; 51:622-629
6. Devine DV, Serrano K: The platelet storage lesion. Clin Lab Med 2010; 30:475-487
7. Nogawa M, Naito Y, Chatani M, et al.: Parallel comparison of apheresis-collected platelet concentrates stored in four different additive solutions. Vox Sang 2013; 105:305-312
8. Ringwald J, Zimmermann R, Eckstein R: The new generation of platelet additive solution for storage at 22 degrees C: development and current experience. Transfus Med Rev 2006; 20:158-164
9. Saunders C, Rowe G, Wilkins K, et al.: Impact of glucose and acetate on the characteristics of the platelet storage lesion in platelets suspended in additive solutions with minimal plasma. Vox Sang 2013; 105:1-10
10. van dMP: Platelet additive solutions: a future perspective. Transfus Clin Biol 2007; 14:522-525
11. Gulliksson H: Platelet storage media. Vox Sang 2014; 107:205-212
12. BMAGS: Blutsicherheitsgesetz; in BMAGS (eds): Bundesgesetz über die Gewinnung von Blut und Blutbestandteilen in Blutspendeeinrichtungen. 1999:1-12.
13. Europe Co: Guide to the Preparation, Use and Quality Assurance of Blood Components, 17th edn. EDQM, European Council, 2013:280.
14. Moog R: Feasibility and safety of triple dose platelet collection by apheresis. J Clin Apheresis 2009; 24:238-240
15. Johnson L, Winter KM, Hartkopf-Theis T, et al.: Evaluation of the automated collection and extended storage of apheresis platelets in additive solution. Transfusion 2012; 52:503-509
16. Jilma-Stohlawetz P, Eichelberger B, List J, et al.: The effect of plasma removal from apheresis platelet concentrates on platelet function. Vox Sang 2012; 102:258-260
17. Jilma-Stohlawetz P, Horvath M, Eichelberger B, et al.: Platelet function under high-shear conditions from platelet concentrates. Transfusion 2008; 48:129-135
18. Dzik S, Moroff G, Dumont L: A multicenter study evaluating three methods for counting residual WBCs in WBC-reduced blood components: Nageotte hemocytometry, flow cytometry, and microfluorometry. Transfusion 2000; 40:513-520
19. van dMP, Kerkhoffs JL, Curvers J, et al.: In vitro comparison of platelet storage in plasma and in four platelet additive solutions, and the effect of pathogen reduction: a proposal for an in vitro rating system. Vox Sang 2010; 98:517-524
20. Holme S, Sweeney JD, Sawyer S, et al.: The expression of p-selectin during collection, processing, and storage of platelet concentrates: relationship to loss of in vivo viability. Transfusion 1997; 37:12-17
21. Tynngard N, Trinks M, Berlin G: In vitro properties of platelets stored in three different additive solutions. Transfusion 2012; 52:1003-1009
22. de W-EJ, Schrijver JG, Bins M, et al.: Storage of platelets in additive solutions: effects of magnesium and/or potassium. Transfusion 2002; 42:76-80
23. Diedrich B, Sandgren P, Jansson B, et al.: In vitro and in vivo effects of potassium and magnesium on storage up to 7 days of apheresis platelet concentrates in platelet additive solution. Vox Sang 2008; 94:96-102
24. Tynngard N, Trinks M, Berlin G: In vitro properties of platelets stored in three different additive solutions. Transfusion 2012; 52:1003-1009
25. Azuma H, Hirayama J, Akino M, et al.: Platelet additive solution - electrolytes. Transfus Apher Sci 2011; 44:277-281
26. Shimizu T, Murphy S: Roles of acetate and phosphate in the successful storage of platelet concentrates prepared with an acetate-containing additive solution. Transfusion 1993; 33:304-310
27. Zhang JG, Carter CJ, Culibrk B, et al.: Buffy-coat platelet variables and metabolism during storage in additive solutions or plasma. Transfusion 2008; 48:847-856